OAM
RLAY icon

Oxford Asset Management’s Relay Therapeutics RLAY Stock Holding History

Oxford Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,521
Closed -$224K – 582
2026
Q1 		$224K Buy
+22,521
New +$201K 0.09% 333
2024
Q2 		– Sell
-16,018
Closed -$133K – 398
2024
Q1 		$133K Buy
+16,018
New +$156K 0.14% 214

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Oxford Asset Management's RLAY Position: Q2 2026 in Review

Oxford Asset Management sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 22,521 shares — an estimated $224K sold.

Oxford Asset Management first reported a position in RLAY in Q1 2024 and held it in 2 quarters. The position peaked at $224K in Q1 2026. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Oxford Asset Management reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Oxford Asset Management sold 22,521 Relay Therapeutics shares in Q2 2026, an estimated $224K.
  • Oxford Asset Management first reported a position in Relay Therapeutics in Q1 2024 and held it in 2 quarters.
  • Oxford Asset Management's Relay Therapeutics position peaked at $224K in Q1 2026.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.